CJC-1295 Acetate

• 

2. Description:

CJC-1295 is a derivative of human GH-releasing factor1-29(HGRF1-29). HGRF1-29 is a naturally occurring peptide that is actually a truncated form of a larger peptide that binds to the growth hormone secretagogue receptor (GHS-R) and causes the release of growth hormone. CJC-1295 has four amino acids substituted in its chain that result in strong binding to serum albumin and prolong its half-life in the body.

Because of the way CJC-1295 is engineered its half life has been extended from ~7 minutes to greater than 7 days!. This is convenient as it means the product only needs to be injected 1-2 times per week for continuously elevated levels of Human Growth Hormone (HGH) and IGF-1. A single subcutaneous (sc) injection results in measurable quantities of CJC-1295 in the blood for up to 13 days. Additionally, a single dose of 60 ug/kg of CJC-1295 results in elevated levels of growth hormone (125%) while the pulsatile secretion of GH is maintained. Furthermore, 60 ug/kg of CJC-1295 elevated IGF-1 levels to the upper limit of normal. A dose of 30 ug/kg of CJC-1295 given weekly maintained its response with no evidence of desensitization.
The advantage of using CJC-1295 instead of actual HGH injections is that injecting HGH shuts down the body's own natural production and therefore when injections are ceased, the body's ability to produce it's own HGH may be impaired and take some time to recover. Since CJC-1295 only stimulates the body's own HGH production, this risk is not apparent.
Another very positive benefit of CJC-1295/CJC-1293 is its ability to promote slow wave sleep. Slow wave sleep is also known as deep sleep and is the portion of sleep responsible for the highest level of muscle growth and memory retention. SWS are decreased significantly in older adults and also with people who tend to exercise later in the evening. This peptide has a benefit to side effect ratio that exceeds all others currently being legally sold and would make a great addition to ones training regimen or post cycle therapy.
Clinical Research was first conducted for CJC-1295 during the mid-2000s. The objective of the peptide was to treat visceral fat deposits in obese AIDS patients, as increased levels of exogenous hgH are presumed to increase lipolysis (fat loss). The clinical research was ultimately successful for most research subjects

Other supplier products

	GRF（human）Acetate	Product Name GRF（human）Acetate Sequence Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Ly...
	Drostanolone Enanthate Injectable Steroids	Basic Info Model NO.:Drostanolone Enanthate Customized:Non-Customized State:Solid Drostanolone Enanthate Injectable:Drostanolone Enanthate Char...
	Bivalirudin Trifluoroacetate	Product Name Bivalirudin Trifluoroacetate Sequence D-Phe-Pro-Arg-Pro-Gly-Gly-Gly-Gly-Asn-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu-OH...
	Boldenone Undecylenate	Boldenone Undecylenate CAS NO.: 13103-34-9 Molecular Formula: C30H44O3 Molecular weight: 452.67 Assay: 97.0~103.0% Standard: Enterprise Standard Ch...
	Finasteride	Detail Quick Detail 1 ) Finasteride 2 ) Alias: Proscar 3 ) CAS No: 98319-26-7 4 ) MF: C23H36N2O2 5 ) MW: 372.55 6 ) Purity: 98.5% ...

Same products

	MONSA® DDAC-50	Seller: Guangzhou Monsa Chemical Co., Ltd	INCI name: MONSA® DDAC-50 It functions by causing the cell membrane of bacteria to rupture...
	MONSA® DCA-50	Seller: Guangzhou Monsa Chemical Co., Ltd	INCI name: disodium cocoampho diacetate Disodium cocoamphodiacetate for skinis a very mild amp...
	MONSA® CTAC-50	Seller: Guangzhou Monsa Chemical Co., Ltd	INCI name: Cetyl Trimethyl Ammonium Chloride Cetyl Trimethyl Ammonium Chloride is an ammonium ...
	MONSA® CTAC-30	Seller: Guangzhou Monsa Chemical Co., Ltd	INCI name: Cetyl Trimethyl Ammonium Chloride 30% Cetyltrimethyl ammonium chloride30% is mainly...
	Common Rail Injector	Seller: DIP (DIESEL INJECTION PARTS) PLANTS	Item: Diesel Fuel Injector　　　　　　　　　 Model No: MOQ: 1pc　　　　　　　　　　　　　　　　Material: SteelPackage Deta...